Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1997 Jun 10;94(12):6153-8.
doi: 10.1073/pnas.94.12.6153.

Engineering subunit association of multisubunit proteins: a dimeric streptavidin

Affiliations

Engineering subunit association of multisubunit proteins: a dimeric streptavidin

T Sano et al. Proc Natl Acad Sci U S A. .

Abstract

A dimeric streptavidin has been designed by molecular modeling using effective binding free energy calculations that decompose the binding free energy into electrostatic, desolvation, and side chain entropy loss terms. A histidine-127 --> aspartic acid (H127D) mutation was sufficient to introduce electrostatic repulsion between subunits that prevents the formation of the natural tetramer. However, the high hydrophobicity of the dimer-dimer interface, which would be exposed to solvent in a dimeric streptavidin, suggests that the resulting molecule would have very low solubility in aqueous media. In agreement with the calculations, a streptavidin containing the H127D mutation formed insoluble aggregates. Thus, the major design goal was to reduce the hydrophobicity of the dimer-dimer interface while maintaining the fundamental structure. Free energy calculations suggested that the hydrophobicity of the dimer-dimer interface could be reduced significantly by deleting a loop from G113 through W120 that should have no apparent contact with biotin in a dimeric molecule. The resulting protein, containing both the H127D mutation and the loop deletion, formed a soluble dimeric streptavidin in the presence of biotin.

PubMed Disclaimer

Figures

Figure 3
Figure 3
Gel filtration chromatography of Stv-43. (A) Purified Stv-43 (approximately 3 μg) with excess d-[carbonyl-14C]biotin was applied to a Superdex 75 HR 10/30 column (1.0 × 30 cm) that had been equilibrated with TTBS. Proteins were eluted at room temperature (22°C) with TTBS, and the absorbance at 280 nm was monitored (solid line). The eluate was collected in 320-μl fractions, and the radioactivity of each fraction was determined (○). The minimum-sized core streptavidin (50.4 kDa) (26) was also analyzed, and the absorbance at 280 nm is shown by a dashed line. (B) Stv-43, which had been stored without bound biotin at 4°C for 7 days, was mixed with excess d-[carbonyl-14C]biotin. The mixture was analyzed by gel filtration chromatography by the same procedure as in A.
Figure 1
Figure 1
(A) Backbone structure of a tetrameric streptavidin. Also shown are the side chains of W120 and H127; the latter is converted to D127 in Stv-33 and Stv-43. (B) Stereo view of the local three-dimensional structure (T106–D128) around the loop region (G113–W120) which has been deleted in Stv-43 (shaded), superimposed on the same sequence of natural streptavidin. These are drawn based on the x-ray structure of natural streptavidin (16, 17) by using molscript (32).
Figure 2
Figure 2
(A) Expression of Stv-43 in E. coli carrying expression vector pTSA-43. Total cell protein of BL21(DE3)(pLysE), with or without pTSA-43, was analyzed by SDS/PAGE (31). Lanes: a, BL21(DE3)(pLysE); b, BL21(DE3)(pLysE)(pTSA-43); and M, molecular mass standard proteins. The number above each lane is the time in hours after induction. The position where Stv-43 migrates is shown by an arrow. Each lane contains the total cell protein from the following volume of culture: at 5 hr for a and at 3 hr and 5 hr for b, 25 μl; at 0 hr and 1 hr for b, 83 μl. (B) SDS/PAGE analysis of purified Stv-43. Approximately 1 μg of purified Stv-43 was analyzed. The right lane contains molecular mass standard proteins.

References

    1. Morrison S L, Canfield S, Porter S, Tan L K, Tao M, Wilms L A. Clin Chem. 1988;34:1668–1675. - PubMed
    1. Morrison S L, Oi V T. Adv Immunol. 1989;44:65–92. - PubMed
    1. Winter G, Milstein C. Nature (London) 1991;349:293–299. - PubMed
    1. Plückthun A. Bio/Technology. 1991;9:545–551. - PubMed
    1. Ward E S. FASEB J. 1992;6:2422–2427. - PubMed

Publication types

MeSH terms

LinkOut - more resources